Pharmacokinetics of venom toxins and their modification by antivenom therapy

Journal of Toxicology - Toxin Reviews

Volumn 22, Issue 1, 2003, Pages 129-138

  Bon, Cassian ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Antivenom; Envenomation; Immunotherapy; Pharmacokinetics; Scorpion; Snake; Venom toxins

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN F(AB) FRAGMENT; VENOM; VENOM ANTISERUM;

DRUG ABSORPTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG MECHANISM; DRUG PURIFICATION; DRUG SAFETY; ENVENOMATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOTHERAPY; REVIEW; SCORPION; SIDE EFFECT; SNAKE;

SCORPIONES; SERPENTES;

EID: 0037239966     PISSN: 07313837     EISSN: None     Source Type: Journal    
DOI: 10.1081/TXR-120019025     Document Type: Review

References (29)

1. Al-Asmari, A. K., al-Abdulla, I. H., Crouch, R. G., Smith, D. C., Sjöström, L. (1997). Assessment of an ovine antivenom raised against venom from the desert black cobra (Walterinnesia aegyptia). Toxicon 35:141-145.
2. Audebert, F., Sorkine, M., Bon, C. (1992). Envenoming by viper bites in France: clinical gradation and biological quantification by ELISA. Toxicon 30:599-609.
3. Audebert, F., Grosselet, O., Sabouraud, A., Bon, C. (1993). Quantitation of venom antigens from European vipers in human serum or urine by ELISA. J. Anal. Toxicol. 17:236-240.
4. Audebert, F., Sorkine, M., Robbe-Vincent, A., Bon, C. (1994a). Viper bites in France: clinical and biological evaluation; kinetics of envenomations. Human Exp. Toxicol. 13:683-688.
5. Audebert, F., Urtizberea, M., Sabouraud, A., Scherrmann, J. M., Bon, C. (1994b). Pharmacokinetics of Vipera aspis venom after experimental envenomation in rabbits. J. Pharmacol. Exp. Ther. 268:1512-1517.
6. Baud, F. J., Sabouraud, A., Vicaut, E., Taboulet, P., Lang, J., Bismuth, C., Rouzioux, J. M., Scherrmann, J. M. (1995). Treatment of severe colchicine overdose with colchicine-specific Fab fragments. N. Engl. J. Med. 332:642-645.
7. Bon, C. (1994). Les venins des serpents et pharmacopées. In: Bauchot, C., ed. Les Serpents. Bordas: Paris, pp. 194-209.
8. Calmette, A. (1894). Contribution à l'étude du venin des serpents. Immunisation des animaux et traitement de l'envenimation. Ann. Inst. Pasteur 8:275-291.
9. Chippaux, J. P., Goyffon, M. (1991). La sérothérapie antivenimeuse: ses applications, ses limites, son avenir. Bull. Soc. Pathol. Exot. 84:286-297.
10. 2 purifiés (Viperfav™) par voie veineuse. Presse Méd. 35:1929-1934.
11. Karlson-Stiber, C., Persson, H., Heath, A., Smith, D., al-Abdulla, I. H., Sjöström, L. (1997). First clinical experiences with specific sheep Fab fragments in snake bite. Report of a multicentre study of Vipera berus envenoming. J. Int. Med. 241:53-58.
12. Malasit, P., Warrell, D. A., Chanthavanich, P., Viravan, C., Mongkolsapaya, J., Singhthong, B., Supich, C. (1986). Prediction, prevention, and mechanism of early (anaphylactic) antivenom reactions in victims of snake bites. Br. Med. J. 292:17-20.
13. Meyer, W. P., Habib, A. G., Onayade, A. A., Yakubu, A., Smith, D. C., Nasidi, A., Daudu, I. J., Warrell, D. A., Theakston, R. D. (1997). First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom. Am. J. Trop. Med. Hyg. 56:291-300.
14. 2 antivenom from hyperimmunized horse: pharmacokinetics following intravenous and intramuscular administrations in rabbits. Pharmaceut. Res. 12:1470-1473.
15. 2 preparations against European viper venoms and the tetanus toxin. Toxicon 35:411-422.
16. 2 against European viper venom. J. Pharm. Sci. 87:221-225.
17. Rivière, G., Choumet, V., Audebert, F., Sabouraud, A., Debray, M., Scherrmann, J. M., Bon, C. (1997). Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy. J. Pharmacol. Exp. Ther. 281:1-8.
18. Rivière, G., Choumet, V., Saliou, B., Debray, M., Bon, C. (1998). Absorption and elimination of viper venom after antivenom administration. J. Pharmacol. Exp. Ther. 285:490-495.
19. Russell, F. E. (1988). Snake venom immunology: historical and practical considerations. J. Toxicol., Toxin Rev. 7:1-82.
20. Sjöström, L., al-Abdulla, I. H., Rawat, S., Smith, D. C., Landon, J. (1994). A comparison of ovine and equine antivenoms. Toxicon 32:427-433.
21. Smith, T. W., Lloyd, B. L., Spicer, N., Haber, E. (1979). Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon. Clin. Exp. Immunol. 36:384-396.
22. Smith, T. W., Butler, V. P. Jr., Haber, E., Fozzard, H., Marcus, F. I., Bremner, W. F., Schulman, I. C., Phillips, A. (1982). Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. N. Engl. J. Med. 307:1357-1362.
23. Smith, D. C., Reddi, K. R., Laing, G., Theakston, R. G., Landon, J. (1992). An affinity purified ovine antivenom for the treatment of Vipera berus envenoming. Toxicon 30:865-871.
24. Theakston, R. D. (1997). An objective approach to antivenom therapy and assessment of first-aid measures in snake bite. Ann. Trop. Med. Parasitol. 91:857-865.
25. Thomas, L., Tyburn, B., Bucher, B., Pecout, F., Ketterlé, J., Rieux, D., Smadja, D., Gamier, D., Plumelle, Y. (1995). Prevention of thromboses in human patients with Bothrops lanceolatus envenoming in Martinique: failure of anticoagulants and efficacy of a monospecific antivenom. Research Group on Snake Bites in Martinique. Am. J. Trop. Med. Hyg. 52:419-426.
26. 2 antivenom serum for Bothrops lanceolatus bites in Martinique. Lancet 347:406.
27. Valentine, J. L., Mayersohn, M., Wessinger, W. D., Arnold, L. W., Owens, S. M. (1996). Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats. J. Pharmacol. Exp. Ther. 278:709-716.
28. Warrell, D. A. (1996). Clinical features of envenoming of snake bites. In: Bon, C., Goyffon, M., eds. Envenoming and Their Treatments Fond. Marcel Mérieux, France, pp. 63-76.
29. World Health Organization, Genova (1981). Progress in the Characterization of Venoms and Standardization of Antivenoms, Vol. 58.